BioInitials AG

BioInitials aims to develop non-invasive medical devices, such as a toothbrush, to monitor health by analyzing biomarkers in saliva. These biomarkers, combined with other data, will be analyzed using artificial intelligence. This approach will not only provide insights into oral health conditions, such as periodontitis and its associated systemic diseases (e.g., diabetes and cardiovascular diseases), but also enable the direct detection of diseases like asthma and COPD. The goal is to detect diseases at an early stage and predict their progression.